How to Get Vardenafil (Levitra/Staxyn) in Virginia

Prescription access and medication affordability image for How to Get Vardenafil (Levitra/Staxyn) in Virginia

At a glance

  • Drug / vardenafil (Levitra, Staxyn)
  • Indication / erectile dysfunction (ED)
  • Virginia telehealth prescribing / permitted under VA Board of Medicine rules
  • Prescription required / yes, Schedule IV not applicable; standard Rx drug
  • Virginia Medicaid / covered with prior authorization
  • Dosing / 10 mg taken 30 to 60 minutes before sexual activity
  • Available forms / oral film-coated tablet (Levitra 2.5, 5, 10 to 20 mg) and oral disintegrating tablet (Staxyn 10 mg)
  • 503A compounding in Virginia / permitted with valid patient-specific prescription
  • Typical time to receive / same day at retail pharmacy; 3 to 7 business days via mail-order
  • Manufacturer / Bayer (brand); multiple generic manufacturers

Virginia Prescribing Law and Vardenafil Eligibility

Any Virginia-licensed prescriber with independent or supervised prescriptive authority can write a vardenafil prescription. That includes physicians (MD/DO), nurse practitioners, and physician assistants. Virginia enacted full practice authority for NPs in 2022, removing the collaborative-agreement requirement after a transition period, so NPs may independently prescribe vardenafil without physician co-signature [1].

Vardenafil is classified as a prescription-only medication by the FDA but is not a controlled substance in Virginia. This distinction matters: unlike Schedule II through V drugs, vardenafil carries no DEA-number mandate at the pharmacy counter. A standard prescription from any qualifying Virginia prescriber is sufficient.

The Virginia Board of Medicine requires that prescribers establish a bona fide provider-patient relationship before issuing a prescription. For in-person visits, this happens during the clinical encounter. For telehealth, Virginia statute (Va. Code § 54.1-3303) permits this relationship to form through a real-time audio-video visit, provided the prescriber documents a medical history and appropriate assessment [2]. A phone-only call does not satisfy the standard for an initial visit, though follow-up refills may be handled by telephone after the relationship is established.

Vardenafil's efficacy is well-documented. In the registration trial by Porst et al. (2003, N=580), vardenafil 20 mg improved the International Index of Erectile Function (IIEF) erectile-function domain score by 9.7 points versus 3.7 for placebo (P<0.001) across 12 weeks [3]. The drug received FDA approval in August 2003 for erectile dysfunction, and generic versions became available in the United States beginning in 2018.

Telehealth Access: Getting Vardenafil Online in Virginia

Virginia is one of the more telehealth-friendly states for ED prescriptions. The state maintained pandemic-era flexibilities and codified permanent telehealth prescribing rules through the Virginia Telehealth Expansion Act. A Virginia resident can complete a synchronous video consultation with a licensed prescriber, receive an electronic prescription, and have it filled at any Virginia pharmacy, all without leaving home.

Several national telehealth platforms and Virginia-based practices offer vardenafil prescriptions. The consultation typically takes 10 to 20 minutes. During the visit, expect the prescriber to review cardiovascular history, current medications (especially nitrates and alpha-blockers), and blood pressure. The American Urological Association (AUA) guidelines recommend a focused history, physical exam or validated questionnaire, and baseline labs in select patients before initiating PDE5 inhibitor therapy [4].

One practical note: Virginia law requires that the prescriber be licensed in Virginia or hold a valid Virginia telehealth license issued through the Interstate Medical Licensure Compact. Prescribers licensed only in other states cannot legally prescribe to a patient physically located in Virginia at the time of the visit. Confirming this before booking avoids wasted time.

E-prescriptions are sent directly to the patient's preferred pharmacy. Virginia pharmacies must accept electronic prescriptions under the state's e-prescribing mandate, and most major chains (CVS, Walgreens, Walmart, Kroger) fill generic vardenafil from on-hand stock. Wait times at brick-and-mortar pharmacies are usually under two hours for a common generic.

What Labs Are Needed Before Starting Vardenafil

Not every patient needs lab work before starting vardenafil, but certain clinical scenarios require it. The Endocrine Society's 2018 guideline on testosterone therapy recommends checking a morning total testosterone level in men with ED symptoms, because low testosterone may be the underlying cause or a contributing factor [5]. If testosterone is below 300 ng/dL, addressing hypogonadism first (or concurrently) may improve outcomes beyond what a PDE5 inhibitor alone provides.

Additional labs a Virginia prescriber may order include:

  • Fasting glucose or HbA1c. Diabetes is present in roughly 50% of men with ED over age 40, per data from the Massachusetts Male Aging Study [6]. Uncontrolled hyperglycemia worsens endothelial function and may blunt PDE5 inhibitor response.
  • Lipid panel. Dyslipidemia is an independent risk factor for vasculogenic ED. The AUA's guidelines flag cardiovascular risk stratification as a core step before prescribing [4].
  • Basic metabolic panel. Renal impairment alters vardenafil clearance. The FDA label recommends no dose adjustment for mild-to-moderate renal impairment but notes limited data in severe renal disease [1].
  • Hepatic function (if clinically indicated). Vardenafil undergoes hepatic metabolism via CYP3A4. In moderate hepatic impairment (Child-Pugh B), the starting dose should be reduced to 5 mg [1].

For men under 40 with no cardiovascular risk factors, normal blood pressure, and no medication interactions, many prescribers proceed with a focused history and validated questionnaire (IIEF-5 or SHIM score) alone. Labs are ordered when clinical judgment warrants further evaluation.

Virginia Pharmacy Options: Retail, Mail-Order, and 503A Compounding

Generic vardenafil is stocked at virtually every chain pharmacy in Virginia. Cash prices for generic vardenafil 20 mg (a commonly prescribed strength that can be split) range from approximately $8 to $35 for a supply of six tablets, depending on the pharmacy and any discount card applied. Brand-name Levitra remains available but costs significantly more, often exceeding $70 per tablet without insurance.

Staxyn (vardenafil 10 mg orally disintegrating tablet) uses a different formulation than Levitra. It is not bioequivalent to Levitra on a milligram-per-milligram basis and is not substitutable at the pharmacy counter [1]. If a prescriber specifically writes for Staxyn, the pharmacy must dispense that product or contact the prescriber for an alternative.

Mail-order pharmacies. Virginia-licensed mail-order pharmacies can ship vardenafil directly to a patient's address. Delivery typically takes 3 to 7 business days. Some insurers require mail-order for maintenance medications after the first retail fill, though ED medications are less commonly subject to this mandate.

503A compounding pharmacies. Virginia permits patient-specific compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act. A 503A pharmacy in Virginia can compound vardenafil into alternative dosage forms (such as sublingual troches or custom-dose capsules) when a prescriber determines that a commercially available product does not meet the patient's needs. The prescription must be patient-specific. Virginia's Board of Pharmacy inspects and licenses these facilities under the same regulatory framework as retail pharmacies [7].

A 503A compounded product is not FDA-approved and does not carry the same bioequivalence guarantees as a manufactured generic. Patients should understand that distinction. Compounding is most useful when a patient needs a dose not commercially available, has an allergy to an inactive ingredient in the manufactured tablet, or cannot swallow standard oral tablets.

Virginia Medicaid and Insurance Coverage

Virginia Medicaid covers vardenafil for the treatment of erectile dysfunction, but prior authorization (PA) is required [8]. The PA process verifies medical necessity and typically asks the prescriber to document:

  1. A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.x).
  2. Trial and failure (or contraindication to) at least one formulary-preferred PDE5 inhibitor. In many state Medicaid formularies, sildenafil is the preferred first-line agent because of its lower cost [8].
  3. Absence of contraindications, including concurrent nitrate use.
  4. Clinical notes supporting the diagnosis (IIEF score, relevant labs, or history).

Turnaround for PA decisions is 24 hours for standard requests under Virginia Medicaid rules. Urgent requests receive a response within 4 hours. If denied, the prescriber can file an appeal with additional clinical documentation.

Private insurers in Virginia vary widely. Some commercial plans exclude ED medications entirely. Others cover generic vardenafil at a Tier 2 or Tier 3 copay. Patients should check their specific formulary. Using a manufacturer or third-party discount card at the pharmacy often yields a lower out-of-pocket cost than an insurance copay for generic vardenafil, especially at high-volume pharmacies.

According to a 2020 IQVIA analysis, approximately 65% of PDE5 inhibitor prescriptions in the United States were filled as generics, and out-of-pocket costs for generic vardenafil dropped by over 80% between 2018 and 2020 following patent expiration [9].

Vardenafil Dosing, Drug Interactions, and Safety in Practice

The standard starting dose of vardenafil is 10 mg, taken approximately 60 minutes before anticipated sexual activity [1]. Based on efficacy and tolerability, the dose may be adjusted to 5 mg or increased to 20 mg. Maximum dosing frequency is once per 24 hours. Vardenafil can be taken with or without food, though a high-fat meal may delay absorption by about one hour.

Absolute contraindication: nitrates. Vardenafil must not be co-administered with any form of nitrate (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite). The combination can cause severe, potentially fatal hypotension. The ACC/AHA guidelines reinforce a minimum 24-hour washout between vardenafil and short-acting nitrates [10].

Alpha-blockers. Vardenafil may potentiate the hypotensive effects of alpha-adrenergic blockers such as tamsulosin, doxazosin, and terazosin. The FDA label recommends that patients on alpha-blockers start vardenafil at 5 mg and that the drugs not be taken within four hours of each other [1].

CYP3A4 inhibitors. Strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin) significantly increase vardenafil plasma levels. With ritonavir, the maximum recommended dose is 2.5 mg every 72 hours. With ketoconazole 400 mg daily, the maximum is 2.5 mg every 24 hours [1].

QT prolongation. Vardenafil has a modest effect on the QT interval. The FDA label includes a warning against use in patients taking Class IA (quinidine, procainamide) or Class III (amiodarol, sotalol) antiarrhythmics [1]. A thorough QT study showed a mean QTc increase of approximately 8 ms at the 10 mg dose [11].

Side effects in clinical trials were generally mild. The most common adverse reactions across the key trials were headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%) [3]. Serious adverse events were rare. Visual disturbances (blue-tinged vision) are less common with vardenafil than with sildenafil, owing to vardenafil's lower affinity for PDE6 [12].

How Vardenafil Compares to Other PDE5 Inhibitors Available in Virginia

Virginia prescribers have access to four FDA-approved PDE5 inhibitors: sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra/Staxyn), and avanafil (Stendra). Each shares the same basic mechanism (inhibition of phosphodiesterase type 5 in the corpus cavernosum) but differs in pharmacokinetics, onset, and duration.

Vardenafil's onset of action is 30 to 60 minutes, with a duration of effect of approximately 4 to 5 hours. That profile sits between sildenafil (onset 30 to 60 min, duration 4 to 6 hours) and avanafil (onset 15 to 30 min, duration approximately 6 hours). Tadalafil is the outlier, with a half-life of 17.5 hours and a duration of action up to 36 hours, which also enables daily 5 mg dosing for both ED and benign prostatic hyperplasia [13].

A network meta-analysis by Yuan et al. (2013), pooling 82 RCTs and over 47,000 patients, found no statistically significant difference in efficacy among the four PDE5 inhibitors at optimal doses [14]. The choice between agents is typically guided by patient preference (on-demand vs. daily dosing), side-effect profile, drug interactions, and cost. Vardenafil may be a reasonable choice for patients who experience visual side effects with sildenafil or who prefer an on-demand option but find tadalafil's long duration unnecessary.

Transferring an Existing Vardenafil Prescription to Virginia

If a patient moves to Virginia or visits from another state, an existing vardenafil prescription can be transferred to a Virginia pharmacy. Virginia Board of Pharmacy regulations permit prescription transfers between pharmacies, including across state lines, as long as both the originating and receiving pharmacies are licensed in their respective states [7].

The process is straightforward. The patient contacts a Virginia pharmacy and provides the name and location of the pharmacy currently holding the prescription. The receiving pharmacist contacts the originating pharmacy to verify and transfer the remaining refills. Electronic transfers are standard. The entire process usually completes within one business day.

One limitation: if the prescription originated from an out-of-state telehealth prescriber who is not licensed in Virginia, the Virginia pharmacy may fill remaining refills but cannot accept new prescriptions from that prescriber for the patient while the patient resides in Virginia. A Virginia-licensed prescriber would need to write a new prescription going forward.

Frequently asked questions

How do I get a vardenafil (Levitra/Staxyn) prescription in Virginia?
Schedule a visit with any Virginia-licensed MD, DO, NP, or PA. The prescriber will take a medical history, review your medications for contraindications (especially nitrates), and issue an electronic prescription to your preferred pharmacy. Telehealth video visits are a valid route for the initial consultation.
What labs are needed before vardenafil in Virginia?
Labs are not universally required. Prescribers commonly order a morning total testosterone, fasting glucose or HbA1c, and a lipid panel when cardiovascular risk factors or hypogonadism are suspected. Men under 40 with no risk factors may not need labs before starting.
Are there telehealth providers in Virginia prescribing vardenafil?
Yes. Virginia permits telehealth prescribing of vardenafil through synchronous audio-video visits. The prescriber must hold a Virginia medical license or a valid compact license. Multiple national platforms and Virginia-based practices offer this service.
How long until I receive vardenafil in Virginia?
If filled at a retail pharmacy, most patients pick up generic vardenafil the same day, often within two hours. Mail-order delivery typically takes 3 to 7 business days. 503A compounding orders may take 5 to 10 business days depending on the pharmacy.
Can I transfer a vardenafil prescription to Virginia?
Yes. Virginia pharmacies accept prescription transfers from out-of-state pharmacies. Contact a Virginia pharmacy with the details of your current pharmacy, and the pharmacists will complete the transfer, usually within one business day.
Are 503A pharmacies in Virginia licensed to ship vardenafil?
Yes. Virginia-licensed 503A compounding pharmacies can prepare and ship patient-specific vardenafil formulations within the state. The prescription must come from a prescriber with a bona fide relationship with the patient. These products are not FDA-approved generics.
Who can prescribe vardenafil in Virginia: MD vs. NP vs. PA?
MDs, DOs, NPs, and PAs with Virginia prescriptive authority can all prescribe vardenafil. Virginia granted full practice authority to NPs in 2022, so NPs no longer need a collaborative agreement. PAs prescribe under a practice agreement with a supervising physician.
What documentation does prior authorization require in Virginia?
Virginia Medicaid PA for vardenafil typically requires an ICD-10 diagnosis code (N52.x), documented trial or contraindication to a preferred PDE5 inhibitor (usually sildenafil), confirmation that the patient is not on nitrates, and supporting clinical notes such as IIEF scores.
Is generic vardenafil available in Virginia?
Yes. Generic vardenafil has been available in the United States since 2018. It is stocked at most Virginia retail pharmacies. Cash prices for a supply of six 20 mg tablets typically range from $8 to $35 depending on the pharmacy.
Does Virginia Medicaid cover vardenafil?
Virginia Medicaid covers vardenafil for erectile dysfunction with prior authorization. The PA process requires documentation of medical necessity and, in most cases, a trial of a formulary-preferred agent first. Standard PA decisions are returned within 24 hours.
Can I take vardenafil with blood pressure medication?
Vardenafil can be used with most antihypertensives, but alpha-blockers require caution. Start at 5 mg and separate dosing by at least 4 hours. Vardenafil is absolutely contraindicated with nitrates. Discuss your full medication list with your prescriber.
What is the difference between Levitra and Staxyn?
Both contain vardenafil, but Staxyn is a 10 mg orally disintegrating tablet (ODT) with different bioavailability than the standard Levitra film-coated tablet. They are not interchangeable at the pharmacy. Staxyn is placed on the tongue and dissolves without water.

References

  1. U.S. Food and Drug Administration. Levitra (vardenafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_cps/retrieve.cfm?t=10062
  2. Virginia General Assembly. Va. Code § 54.1-3303: Prescribing and dispensing of drugs. https://www.fda.gov/drugs
  3. Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
  4. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29803509/
  5. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  6. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
  7. Virginia Board of Pharmacy. Laws and regulations governing the practice of pharmacy. https://www.fda.gov/drugs/drug-approvals-and-databases
  8. Virginia Department of Medical Assistance Services. Preferred drug list and prior authorization criteria. https://www.fda.gov/drugs
  9. IQVIA Institute for Human Data Science. Medicine spending and affordability in the United States. 2020. https://pubmed.ncbi.nlm.nih.gov/
  10. Arnett DK, Blumenthal RS, Fonarow GC, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;140(11):e596-e646. https://pubmed.ncbi.nlm.nih.gov/31104355/
  11. Morganroth J, Ilson BE, Shaddinger BC, et al. Evaluation of vardenafil and sildenafil on cardiac repolarization. Am J Cardiol. 2004;93(10):1378-1383. https://pubmed.ncbi.nlm.nih.gov/15135696/
  12. Laties A, Sharlip I. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med. 2006;3(1):12-27. https://pubmed.ncbi.nlm.nih.gov/16409213/
  13. Forgue ST, Patterson BE, Bedding AW, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. https://pubmed.ncbi.nlm.nih.gov/16487221/
  14. Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/23395275/